Skip to main navigation Skip to search Skip to main content

CTU: First-in-Human, Phase 1 Study of ADCE-T02, a Targeting Tissue Factor Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors

  • Parsonson, Andrew (Primary Chief Investigator)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Armstrong, Emilia (Clinical Trial Unit Staff)
  • Lawrie, Angus (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleADCE-T02-001
StatusActive
Effective start/end date23/09/253/09/26